Evidence map›Paper›PMID 33246427›Full record

ArticleBMC nephrology2020

Machine learning algorithm for early detection of end-stage renal disease.

Zvi Segal, Dan Kalifa, Kira Radinsky, Bar Ehrenberg, Guy Elad, Gal Maor, Maor Lewis, Muhammad Tibi, Liat Korn, Gideon Koren

Abstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zvi SegalDiagnostic Robotics Inc., Ariel, Israel.
Dan KalifaDiagnostic Robotics Inc., Ariel, Israel.
Kira RadinskyDiagnostic Robotics Inc., Ariel, Israel.
Bar EhrenbergDiagnostic Robotics Inc., Ariel, Israel.
Guy EladDiagnostic Robotics Inc., Ariel, Israel.
Gal MaorDiagnostic Robotics Inc., Ariel, Israel.
Maor LewisDiagnostic Robotics Inc., Ariel, Israel.
Muhammad TibiDiagnostic Robotics Inc., Ariel, Israel.
Liat KornAriel University, Ariel, Israel.
Gideon KorenAriel University, Ariel, Israel. gidiup_2000@yahoo.com.ORCID 0000-0002-9234-0875

Funding

Diagnostic Robotics Inc 001
6 · The paper itself

Abstract

backgroundEnd stage renal disease (ESRD) describes the most severe stage of chronic kidney disease (CKD), when patients need dialysis or renal transplant. There is often a delay in recognizing, diagnosing, and treating the various etiologies of CKD. The objective of the present study was to employ machine learning algorithms to develop a prediction model for progression to ESRD based on a large-scale multidimensional database.

methodsThis study analyzed 10,000,000 medical insurance claims from 550,000 patient records using a commercial health insurance database. Inclusion criteria were patients over the age of 18 diagnosed with CKD Stages 1-4. We compiled 240 predictor candidates, divided into six feature groups: demographics, chronic conditions, diagnosis and procedure features, medication features, medical costs, and episode counts. We used a feature embedding method based on implementation of the Word2Vec algorithm to further capture temporal information for the three main components of the data: diagnosis, procedures, and medications. For the analysis, we used the gradient boosting tree algorithm (XGBoost implementation).

resultsThe C-statistic for the model was 0.93 [(0.916-0.943) 95% confidence interval], with a sensitivity of 0.715 and specificity of 0.958. Positive Predictive Value (PPV) was 0.517, and Negative Predictive Value (NPV) was 0.981. For the top 1 percentile of patients identified by our model, the PPV was 1.0. In addition, for the top 5 percentile of patients identified by our model, the PPV was 0.71. All the results above were tested on the test data only, and the threshold used to obtain these results was 0.1. Notable features contributing to the model were chronic heart and ischemic heart disease as a comorbidity, patient age, and number of hypertensive crisis events.

conclusionsWhen a patient is approaching the threshold of ESRD risk, a warning message can be sent electronically to the physician, who will initiate a referral for a nephrology consultation to ensure an investigation to hasten the establishment of a diagnosis and initiate management and therapy when appropriate.

Indexed as

Machine LearningRenal Insufficiency, ChronicAlgorithmsDatabases, FactualDisease ProgressionEarly DiagnosisFemaleHumansKidney Failure, ChronicLogistic ModelsMaleMiddle AgedPredictive Value of TestsPrognosisROC CurveAlgorithmEnd stage renal diseaseMachine learningPrediction model

Identifiers

PMID33246427
PMCPMC7693522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.